NCT07139964 - High-Dose Vitamin D3 for Diabetic Foot Ulcer Healing: Randomized Controlled Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

July 31, 2025

Conditions

Diabetic Foot UlcerVitamin D DeficiencyWound Healing Disorder

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Participants receive oral vitamin D3 (cholecalciferol) 10,000 IU daily for 28 consecutive days, in addition to standard diabetic foot ulcer care according to hospital protocols. Vitamin D3 is provided in identical-appearing capsules. Compliance is monitored using the MMAS-8 adherence scale.

OTHER

Placebo

Participants receive an oral placebo capsule daily for 28 consecutive days, in addition to standard diabetic foot ulcer care according to hospital protocols. The placebo is identical in appearance to the vitamin D3 capsule. Compliance is monitored using the MMAS-8 adherence scale.

Trial Locations (1)

Unknown

Dr. Mohammad Hoesin General Hospital, Palembang

All Listed Sponsors

lead

Universitas Sriwijaya

OTHER